← Back to Clinical Trials
Recruiting NCT07180316

NCT07180316 Comparison of the Occurrence of Postoperative Complications Between Robotic and Laparoscopic Surgery in Revision Bariatric Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07180316
Status Recruiting
Phase
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition Obesity and Overweight
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2025-06-17
Primary Completion 2029-06-30

Trial Parameters

Condition Obesity and Overweight
Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2025-06-17
Completion 2029-06-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In a population of patients undergoing bariatric revision surgery with conversion to RYGB and divided into two groups according to the surgical protocol: Group 1: robotic surgery Group 2: laparoscopy The primary objective of the study is to compare the rates of postoperative complications between the two groups, classified according to the Clavien Dindo classification. The secondary objectives are to compare between the groups: * Total duration of the surgical procedure, stay in the emergency room, and hospitalization * Postoperative pain * Adverse events * Weight loss * Improvement in comorbidities

Eligibility Criteria

Inclusion Criteria: * Patients aged 18 to 70 years, * Patients who have been informed of the objectives and conditions of the study and who have not objected to the collection of their data * Patients who are candidates for or have undergone revision bariatric surgery with conversion to RYGB (post-ring, post-sleeve, post-OAGB) Exclusion Criteria: * Pregnant patient * Patient unable to understand information: dementia, psychosis, impaired consciousness, language difficulties

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology